Inventor · disambiguated record
Likun Gong
Also filed as: GONG LIKUN
0 granted patents·8 pending applications·0 citations·filing 2013–2023
Top patents by PatentIndex Score
8 records- 0158US2025197503A1ANTI-HUMAN PD-Ll AND TLR7 DOUBLE-TARGETING NANOBODY CONJUGATE DRUG AND USE THEREOF IN RESISTING TUMORSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 0258US2024261391A1Tlr7 agonist conjugated peptide-based novel coronavirus nanoemulsion vaccine and preparation thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 0357US2025223599A1Preparation and anti-tumor application of gene therapy vector interfering cklf-like marvel transmembrane domain-containing protein 6 (cmtm6) expressionSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 0457US2025009871A1Application of novel coronavirus vaccine peptide and nanoemulsion preparation thereof in prevention of novel coronavirus wild and mutant strainsSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 0553US2023338510A1Novel coronavirus tandem epitope polypeptide vaccine and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 0652US2023241204A1Polypeptide vaccine coupled with tlr7 agonist for novel coronavirus and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Application pending·0 cites
- 0751US2024189443A1Pd-l1 and tlr7 double-targeting nanobody coupling drug and use thereof in anti-tumorSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 0837US2015252365A1Method for screening micrornas with gene silencing function at both levels of transcription and post-transcriptionSHANGHAI INST MATERIA MEDICA·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Likun Gong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →